ImmunityBio Inc.
IBRX | NASDAQ
$8.94
+$0.49 (+5.80%)
Sep 22, 2026, 12:18 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 51.24M | 44.21M | 38.29M | 32.06M | 26.43M | 16.52M | 7.55M | 6.11M | 1.05M | 40K | 139K | 82K | 41K | 360K | 73K | 118K | 35K | 14K | 390K | 66K | 339K | 139K |
Cost of Revenue | 298K | 238K | 4.25M | 4.13M | 136K | 58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.28M | 6.88M | 5.98M | 5.93M | 5.41M | n/a | n/a | n/a | n/a |
Gross Profit | 50.94M | 43.97M | 34.04M | 27.93M | 26.29M | 16.46M | 7.55M | 6.11M | 1.05M | 40K | 139K | 82K | 41K | -5.92M | -6.81M | -5.86M | -5.9M | -5.39M | 390K | 66K | 339K | 139K |
Operating Income | -61.7M | -69.79M | -64.68M | -55.63M | -71.29M | -64.43M | -69.4M | -80.25M | -99.33M | -95.2M | -85.39M | -80.14M | -85.15M | -111.58M | -84.22M | -90.8M | -79.62M | -95.97M | -79.27M | -78.84M | -85.91M | -86.26M |
Interest Income | 3.16M | 2.32M | 3.26M | 2.1M | 818K | 520K | 769K | 638K | 833K | 2.42M | 1.84M | 610K | 592K | 284K | 515K | 253K | 644K | 1.3M | 284K | 101K | 112K | 339K |
Pretax Income | -230.39M | -632.79M | -62.09M | -67.31M | -92.31M | -129.9M | -59.18M | -85.75M | -134.58M | -134.13M | -233.45M | -95.64M | -138.21M | -116.58M | -108.29M | -111.16M | -94.84M | -103M | -91.55M | -88.43M | -89.38M | -80.48M |
Net Income | -230.38M | -632.78M | -61.94M | -67.25M | -92.56M | -129.65M | -59.16M | -85.73M | -134.56M | -134.11M | -233.39M | -95.58M | -137.88M | -116.34M | -108.22M | -110.94M | -94.59M | -102.83M | -91.26M | -87.63M | -88.29M | -79.61M |
Selling & General & Admin | 50.63M | 44.46M | 37.83M | 32.83M | 42.34M | 32.65M | 41.73M | 35.92M | 49.25M | 41.89M | 33.11M | 31.82M | 32.02M | 26.9M | 24.56M | 17.84M | 15.09M | 39.29M | 27.91M | 29.63M | 32.45M | 45.28M |
Research & Development | 57.69M | 64.77M | 60.81M | 50.73M | 55.24M | 48.23M | 35.22M | 50.44M | 51.13M | 53.35M | 51.53M | 48.4M | 53.17M | 78.76M | 52.85M | 67.11M | 58.64M | 51.29M | 51.75M | 49.28M | 53.8M | 41.13M |
Other Expenses | 4.32M | 4.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 886K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -59K | -38K | n/a | 13K |
Operating Expenses | 112.64M | 113.76M | 98.72M | 83.56M | 97.57M | 80.89M | 76.95M | 86.36M | 100.38M | 95.24M | 85.53M | 80.22M | 85.19M | 105.66M | 77.41M | 84.95M | 73.73M | 90.58M | 79.66M | 78.9M | 86.25M | 86.4M |
Interest Expense | 20K | 28.46M | 27.19M | 27.58M | 28.88M | 28.87M | 14.91M | 40.25M | 39.02M | 37.49M | 32.13M | 35.02M | 32.24M | 29.56M | 28.56M | 16.76M | 9.7M | 8.49M | 4.49M | 3.61M | 3.58M | 3.17M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 112.94M | 114M | 102.97M | 87.69M | 97.71M | 80.95M | 76.95M | 86.36M | 100.38M | 95.24M | 85.53M | 80.22M | 85.19M | 111.94M | 84.29M | 90.92M | 79.66M | 95.99M | 79.66M | 78.9M | 86.25M | 86.4M |
Income Tax Expense | n/a | -9K | -135K | -35K | 269K | -234K | n/a | n/a | n/a | n/a | -40K | n/a | n/a | n/a | 34K | n/a | n/a | n/a | 1K | n/a | 2K | 6K |
Shares Outstanding (Basic) | 1.05B | 1.03B | 989.68M | 946.6M | 888.22M | 853.16M | 733.2M | 695.9M | 686.94M | 672.83M | 590.73M | 498.38M | 437.46M | 428.38M | 403.64M | 400.06M | 397.99M | 397.88M | 397.12M | 391.85M | 384.82M | 382.74M |
Shares Outstanding (Diluted) | 1.05B | 1.03B | 989.68M | 946.6M | 888.22M | 853.16M | 734.54M | 697.96M | 686.94M | 672.83M | 590.73M | 498.38M | 437.46M | 428.38M | 403.64M | 400.06M | 397.99M | 397.88M | 397.12M | 391.85M | 384.82M | 382.74M |
EPS (Basic) | -0.22 | -0.62 | -0.06 | -0.07 | -0.10 | -0.15 | -0.08 | -0.12 | -0.20 | -0.20 | -0.40 | -0.19 | -0.32 | -0.35 | -0.27 | -0.28 | -0.24 | -0.26 | -0.23 | -0.22 | -0.23 | -0.21 |
EPS (Diluted) | -0.22 | -0.62 | -0.06 | -0.07 | -0.10 | -0.15 | -0.09 | -0.12 | -0.20 | -0.20 | -0.40 | -0.19 | -0.32 | -0.35 | -0.27 | -0.28 | -0.24 | -0.26 | -0.23 | -0.22 | -0.23 | -0.21 |
EBITDA | -221.58M | -599.95M | -31.04M | -35.77M | -59.54M | -97.21M | -40.12M | -41.07M | -91.16M | -97.64M | -196.76M | -56.08M | -101.3M | -80.75M | -72.88M | -88.41M | -78.75M | -88.05M | -81.88M | -79.86M | -81.82M | -72.56M |
EBIT | -230.37M | -604.33M | -34.9M | -39.73M | -63.42M | -101.04M | -44.27M | -45.51M | -95.57M | -102.19M | -201.33M | -60.62M | -105.98M | -87.03M | -79.76M | -94.39M | -84.68M | -93.46M | -87.06M | -84.82M | -85.81M | -77.31M |
Depreciation & Amortization | 8.79M | 4.38M | 3.87M | 3.95M | 3.88M | 3.83M | 4.15M | 4.44M | 4.41M | 4.56M | 4.56M | 4.54M | 4.68M | 6.28M | 6.88M | 5.98M | 5.93M | 5.41M | 4.98M | 4.92M | 3.98M | 4.53M |
Add to Watchlist
Select watchlists to add or remove IBRX